These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17478153)

  • 1. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.
    Molhoek SG; Bax JJ; Bleeker GB; Boersma E; van Erven L; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Dec; 94(12):1506-9. PubMed ID: 15589005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of atrial fibrillation after cardiac resynchronization therapy.
    Adelstein EC; Saba S
    Am J Cardiol; 2007 Jul; 100(2):268-72. PubMed ID: 17631081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation.
    Ghanbari H; Hassunizadeh B; Machado C
    Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
    Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
    Hoppe UC; Casares JM; Eiskjaer H; Hagemann A; Cleland JG; Freemantle N; Erdmann E
    Circulation; 2006 Jul; 114(1):18-25. PubMed ID: 16801461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.
    Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC;
    J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
    Lellouche N; De Diego C; Vaseghi M; Buch E; Cesario DA; Mahajan A; Wiener I; Fonarow GC; Boyle NG; Shivkumar K
    Pacing Clin Electrophysiol; 2007 Nov; 30(11):1363-8. PubMed ID: 17976100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P; Tulner SA; Bax JJ; Oemrawsingh PV; Bleeker GB; van Erven L; Putter H; Verwey HF; van der Wall EE; Schalij MJ
    Circulation; 2006 Mar; 113(10):1295-304. PubMed ID: 16520415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.